logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

SINO-OCEAN GP(03377): The hearing for the UK restructuring plan application has ended, and the court will reserve judgment on the outcome.

date
07:23 21/01/2025
avatar
GMT Eight
Ocean Group (03377) announced that its application for approval of the UK restructuring plan will be sought from January 15, 2025...
SINO-OCEAN GP (03377) announced that it is seeking approval for its restructuring plan in the UK. A hearing for the application will be held from January 15th to 20th, 2025. The English court reserves the right to make a judgment.
Related Articles
New Stock News | Gao Guang Pharmaceuticals submitted application to Hong Kong Stock Exchange.
HK Bull/Bear Outstanding Qty Ratio(62:38) | December 5th
HK Stock
TRANSCENTA-B (06628): Clover Pharmaceuticals announced updated efficacy data for the first-line treatment of stomach or gastroesophageal junction adenocarcinoma with osemitamab triplet therapy in the I/II phase (Transtar102) at ESMO Asia.
New Stock News | Gao Guang Pharmaceuticals submitted application to Hong Kong Stock Exchange.
HK Bull/Bear Outstanding Qty Ratio(62:38) | December 5th
TRANSCENTA-B (06628): Clover Pharmaceuticals announced updated efficacy data for the first-line treatment of stomach or gastroesophageal junction adenocarcinoma with osemitamab triplet therapy in the I/II phase (Transtar102) at ESMO Asia.
HK Stock
RECOMMEND
Stella McCartney and H&M Reunite to Advance Sustainable Fashion in 2026
Stella McCartney and H&M Reunite to Advance Sustainable Fashion in 2026
icon
04/12/2025
Tariff Reductions Deliver Significant Tailwind To Hyundai And GM
Tariff Reductions Deliver Significant Tailwind To Hyundai And GM
icon
04/12/2025
Celebrity Campaigns Ignite a New Denim Battle Among Major Retailers
Celebrity Campaigns Ignite a New Denim Battle Among Major Retailers
icon
04/12/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.